Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-016860
Filing Date
2019-06-13
Accepted
2019-06-13 17:14:17
Documents
1
Period of Report
2019-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3999
  Complete submission text file 0000899243-19-016860.txt   5511
Mailing Address C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560
Business Address
Vickers Philip J. (Reporting) CIK: 0001635046 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38537 | Film No.: 19896845

Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Issuer) CIK: 0001681087 (see all company filings)

EIN.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)